Valeant Pharmaceuticals reported $1.25B in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Amgen AMGN:US $ 6528M 1461M
Ani Pharmaceuticals ANIP:US $ 76.91M 23.39M
Aurora Cannabis Inc ACB:CN 429.89M 97.49M
Biogen BIIB:US $ 1749.3M 512.1M
Bristol Myers Squibb BMY:US $ 12369M 1610M
Canopy Growth Corp WEED:CN C$ 776M 582.53M
Catalent CTLT:US $ 786M 63M
Corcept Therapeutics CORT:US $ 61.86M 15.76M
Danaher DHR:US $ 3717M 1131M
Eli Lilly And LLY:US $ 2459.2M 1359.3M
Endo International Ordinary Shares ENDP:US $ 1413.15M 94.05M
Gilead Sciences GILD:US $ 4296M 1042M
Horizon Pharma HZNP:US $ 1643.13M 62.81M
Lannett LCI:US $ 106.11M 7.47M
Nektar Therapeutics NKTR:US $ 67.99M 42.78M
Pacira Pharmaceuticals PCRX:US $ 226.75M 358.83M
Perrigo Ordinary Shares PRGO:US $ 1965.5M 100.6M
Phibro Animal Health PAHC:US $ 70.75M 7.36M
Prestige Brands PBH:US $ 27.18M 6.17M
Revance Therapeutics RVNC:US $ 198.36M 87.74M
Supernus Pharmaceuticals SUPN:US $ 115.72M 87.72M
Valeant Pharmaceuticals VRX:CN $ 1249M 667M
Vertex Pharmaceuticals VRTX:US $ 7600.1M 805.1M
Zoetis ZTS:US $ 3132M 350M